Search results for "union"

Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”

Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”

Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has seen prescriptions rise sharply...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous injections to subcutaneous...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
When Staying Is More Dangerous Than Leaving: The Warning Signs of a Toxic Marriage

When Staying Is More Dangerous Than Leaving: The Warning Signs of a Toxic Marriage

"I hope you two don't live together anymore." This blunt statement from renowned counselor Lee Ho-sun during a recent...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
Arranged vs. Romantic Marriage: Is One Truly Happier Than the Other?

Arranged vs. Romantic Marriage: Is One Truly Happier Than the Other?

With the rise of dating apps and social media, opportunities to find a partner have increased significantly compared to...
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
Is ‘Dubai Chonduk’ the Solution?… Decrease in Blood Donations, Unexpected Solutions?

Is ‘Dubai Chonduk’ the Solution?… Decrease in Blood Donations, Unexpected Solutions?

A warning light has turned on for the national blood reserves. With a decrease in blood donation participation and an...